Optimization of a Dibenzodiazepine Hit to a Potent and Selective Allosteric PAK1 Inhibitor.

作者: Alexei S. Karpov , Payman Amiri , Cornelia Bellamacina , Marie-Helene Bellance , Werner Breitenstein

DOI: 10.1021/ACSMEDCHEMLETT.5B00102

关键词:

摘要: The discovery of inhibitors targeting novel allosteric kinase sites is very challenging. Such compounds, however, once identified could offer exquisite levels selectivity across the kinome. Herein we report our structure-based optimization strategy a dibenzodiazepine hit 1, discovered in fragment-based screen, yielding highly potent and selective PAK1 such as 2 3. Compound was cocrystallized with to confirm binding an site reveal key interactions. 3 modulated at cellular level due its enabled valuable research interrogate biological functions kinase.

参考文章(28)
Christy C. Ong, Adrian M. Jubb, Wei Zhou, Peter M. Haverty, Adrian L. Harris, Marcia Belvin, Lori S. Friedman, Hartmut Koeppen, Klaus P. Hoeflich, p21-activated kinase 1: PAK’ed with potential Oncotarget. ,vol. 2, pp. 491- 496 ,(2011) , 10.18632/ONCOTARGET.271
Claire Chong, Lydia Tan, Louis Lim, Edward Manser, The Mechanism of PAK Activation AUTOPHOSPHORYLATION EVENTS IN BOTH REGULATORY AND KINASE DOMAINS CONTROL ACTIVITY Journal of Biological Chemistry. ,vol. 276, pp. 17347- 17353 ,(2001) , 10.1074/JBC.M009316200
B. M. Dolan, S. G. Duron, D. A. Campbell, B. Vollrath, B. S. S. Rao, H.-Y. Ko, G. G. Lin, A. Govindarajan, S.-Y. Choi, S. Tonegawa, Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 110, pp. 5671- 5676 ,(2013) , 10.1073/PNAS.1219383110
Jin-Hun Jung, Jolinda A. Traugh, Regulation of the interaction of Pak2 with Cdc42 via autophosphorylation of serine 141. Journal of Biological Chemistry. ,vol. 280, pp. 40025- 40031 ,(2005) , 10.1074/JBC.M509075200
Julien Viaud, Jeffrey R. Peterson, An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently. Molecular Cancer Therapeutics. ,vol. 8, pp. 2559- 2565 ,(2009) , 10.1158/1535-7163.MCT-09-0102
Sandra W Cowan-Jacob, Wolfgang Jahnke, Stefan Knapp, Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases Future Medicinal Chemistry. ,vol. 6, pp. 541- 561 ,(2014) , 10.4155/FMC.13.216
Maria Radu, Galina Semenova, Rachelle Kosoff, Jonathan Chernoff, PAK signalling during the development and progression of cancer. Nature Reviews Cancer. ,vol. 14, pp. 13- 25 ,(2014) , 10.1038/NRC3645
Silvia Licciulli, Jasna Maksimoska, Chun Zhou, Scott Troutman, Smitha Kota, Qin Liu, Sergio Duron, David Campbell, Jonathan Chernoff, Jeffrey Field, Ronen Marmorstein, Joseph L. Kissil, FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas. Journal of Biological Chemistry. ,vol. 288, pp. 29105- 29114 ,(2013) , 10.1074/JBC.M113.510933
S Jagadeeshan, YR Krishnamoorthy, M Singhal, A Subramanian, J Mavuluri, A Lakshmi, A Roshini, G Baskar, M Ravi, LD Joseph, K Sadasivan, A Krishnan, AS Nair, G Venkatraman, SK Rayala, None, Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis Oncogene. ,vol. 34, pp. 455- 464 ,(2015) , 10.1038/ONC.2013.576
Tian Xie, Wei Peng, Yexing Liu, Chuangye Yan, Jenny Maki, Alexei Degterev, Junying Yuan, Yigong Shi, Structural Basis of RIP1 Inhibition by Necrostatins. Structure. ,vol. 21, pp. 493- 499 ,(2013) , 10.1016/J.STR.2013.01.016